WO2000032097A1 - System and method for executing a treatment regimen - Google Patents
System and method for executing a treatment regimen Download PDFInfo
- Publication number
- WO2000032097A1 WO2000032097A1 PCT/US1999/028296 US9928296W WO0032097A1 WO 2000032097 A1 WO2000032097 A1 WO 2000032097A1 US 9928296 W US9928296 W US 9928296W WO 0032097 A1 WO0032097 A1 WO 0032097A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- information
- patient
- medication
- treatment regimen
- regimen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
Definitions
- Known methods do not provide adequate feedback to determine whether patients are complying with the treatment regimen unless the remain relatively local to client devices.
- Known methods do not provide adequate feedback to determine whether treatment regimens are effective, or whether patients are suffering any untoward side effects.
- medical personnel must generally wait for patients to comply, or for medical test to show, that prescribed treatment regimens are inadequate or are producing side effects.
- patients undertaking unprescribed treatment regimens generally do not have effective or convenient systems to monitor and record whether non-prescribed treatment regimens are producing intended results.
- a portable device that can be coupled and uncoupled to a communication system with feedback to monitor patient compliance, and effectiveness of, treatment regimens, so that input from patients regarding treatment regimens can be recorded, reviewed, analyzed and otherwise generally acted upon.
- Medical personnel and/or patients can thus (1) monitor compliance with treatment regimens, (2) monitor effectiveness or side effects of treatment regimens, (3) remind patients no more than necessary, and (4) possibly alter treatment regimens in response to feedback from patients.
- the portable device is intermittently coupled to a client device in a client-server system
- the patient enters information to the portable device about following the treatment regimen while the portable device is uncoupled, and medical personnel or the patient can receive that information and possibly alter the behavior of the portable device when the portable device is recoupled to the system.
- a medicine dispenser is coupled to a client device in a client-server system
- the patient enters information to the client device about following the medical regimen, and medical personnel can receive that information and possibly alter the behavior of the client device or the medicine dispenser.
- the invention provides a method system for interaction with a community of individuals, relating to compliance with and effectiveness of treatment regimens, including supply and use of pharmaceuticals, using a protocol or other intelligent message which acts in place of a service provider and which is capable of collecting or imparting information to patients in place thereof. Individuals interact with the protocol or intelligent message to provide assistance in all aspects of treatment regimen compliance, data collection, supply or delivery, review and modification.
- These aspects can include (1) reminders regarding compliance with the selected treatment regimen for medication, physical therapy, psychological therapy, self-improvement, or some combination thereof; (2) data collection of facts regarding patient compliance, symptomology, possible drug interactions or side effects of medication if required by the treatment regimen, and other facts relevant to evaluation and possible modification of the treatment regimen; (3) network integration with workstations for medical professionals to automate approvals and modifications, and refills and delivery of medication if required by the treatment regimen.
- a system includes a set of client devices and a server device.
- a service provider determines the treatment regimen for selected patients, determines a protocol to be followed by the client devices to assist the patient in complying with that treatment regimen [in assisting with that medication regimen] and to maximize effectiveness of treatment, and sends that protocol to the server device.
- the server device can update (responsive to the protocol) selected instructions at the client devices, and can receive (responsive to selected instructions) information from the client devices regarding their associated patients.
- a client device located locally to a patient, couples to a portable device, such as a cellular telephone, pager, Palm pilot or other handheld computer, or watch, capable of being carried away by the patient to locations relatively remote from client device.
- the client device can interact with the portable device: (1) to provide the portable device with capability of reminding the patient regarding the treatment regimen; or (2) to provide the portable device with the capability of further data collection regarding patient.
- FIGURE 1 shows a block diagram of a medical appliance system formed in accordance with the present invention
- FIGURE 2 is a block diagram of a first preferred embodiment of a portable device formed in accordance with the present invention
- FIGURE 3 is a flow diagram for operating the system illustrated in FIGURES 1 and 2;
- FIGURE 4 shows a first embodiment of a controlled medication dispenser formed in accordance with the present invention
- FIGURE 5 shows a second embodiment of a controlled medication dispenser formed in accordance with the present invention
- FIGURE 6 shows a third embodiment of a controlled medication dispenser formed in accordance with the present invention
- FIGURE 7 shows a fourth embodiment of a controlled medication dispenser formed in accordance with the present invention
- FIGURE 8 shows a fifth embodiment of a controlled medication dispenser formed in accordance with the present invention.
- FIGURE 9 shows a sixth embodiment of a controlled medication dispenser formed in accordance with the present invention.
- FIGURE 10 shows a seventh embodiment of a controlled medication dispenser formed in accordance with the present invention.
- FIGURE 11 shows a method for performing the invention as described in FIGURES 4-10. Detailed Description Of Preferred Embodiment
- FIGURE 1 shows a block diagram of the system 100 to encourage and monitor compliance with a treatment regimen using a protocol or other intelligent message, which acts in place of a service provider to collect and impart information relevant to the treatment regimen.
- System 100 includes a patient device 110, a pharmacist device 140, a medical professional device 150, and a server device 160. The devices are coupled using a communication network 130.
- a portable device 112 is coupled to the patient device 110 to receive information regarding the treatment regimen and send feedback from the patient 111 responsive thereto.
- a medication dispenser 109 is coupled to the portable device 112 or the patient device 110.
- FIGURE 2 shows the preferred embodiment of the portable device 112 used by the system 100.
- the portable device 112 and medication dispenser 109 has its own power source 119 and includes a coupling element 113 for coupling the portable device 112 to the patient device 110, a memory device 114, a processor chip 115 including a clock circuit 116, a presentation element 117, and a patient feedback input element 118.
- a service provider determines a treatment regimen for selected patients 111 and a protocol to be followed by their portable devices 112 to assist the patients 111 in following the treatment regimen.
- the service provider sends the treatment regimen and protocol to the server device 160 where it is recorded in the database 161.
- the server device 160 sends the treatment regimen and protocol information to the patient device 110, and optionally to the pharmacist device 140 and the medical professional device 150.
- the portable device 112 is coupled to the patient device 110 using the coupling element 113.
- the coupling element 113 may couple using a docking station, an infrared connection, a radio-frequency connection, a plug-in connection, other suitable means or any variance thereof.
- the treatment regimen and protocol information received by the patient device 110 is sent to the portable device 112 and recorded in the memory 114.
- the power source 119 is rechargeable and the charge can be replenished by the patient device 110 while the portable device 112 is coupled to it.
- the power source 119 is rechargeable and the charge can be replenished by some other device, or includes one or more disposable batteries.
- the portable device 112 uses a presentation element 117 to provide a reminder message instructing the patient 111 to perform that act.
- the act to be performed is related to compliance with a medication regimen including, without limitation, obtaining medicine, taking medicine, taking medicine with another substance such as food or water, not taking medicine with another substance such as alcohol or incompatible medications, or obtaining a prescription refill.
- the act to be performed may be pursuant to a physical therapy regimen including, without limitation, exercising, stretching, changing position, or changing work routine; pursuant to a psychological therapy regimen including, without limitation, repeating an affirmation, meditation, self-hypnosis or other mental activity; or pursuant to a self-help regimen or other type of treatment regimen such as weight loss including, without limitation, drinking water or eating a snack.
- a physical therapy regimen including, without limitation, exercising, stretching, changing position, or changing work routine
- a psychological therapy regimen including, without limitation, repeating an affirmation, meditation, self-hypnosis or other mental activity
- a self-help regimen or other type of treatment regimen such as weight loss including, without limitation, drinking water or eating a snack.
- the patient 111 performs the indicated act and enters a message into the portable device 112 coirfirming performance of the act using the patient feedback input element 118. Operation of the patient feedback input element 118 causes the processor chip 115 to cancel the reminder message, check the clock 116, and recorded the time and fact of performance in the memory 114.
- the patient 111 also enters additional information relevant to monitoring and evaluating the treatment regimen in response to queries by the presentation element 117 in accordance with the treatment regimen and protocol.
- the number of reminder messages provided to the patient 111, and the number of messages from the patient 111 confirming performance of the indicated acts and/or providing other information relevant to compliance with and effectiveness of the treatment regimen, is limited only by the memory capacity of the portable device 112.
- the presentation element 117 is a human readable visual display using LCD's, LCD's, or other suitable devices.
- the presentation element 117 can be a device, which produces human-intelligible sound, or a combination of devices, which produce human-intelligible visual and audible signals.
- the portable device 112 is re-coupled to the patient device 110 using the coupling element 113, causing the contents of the memory 114 to be downloaded into the patient device 110 and sent to the server device 160 for recording in the database 161.
- Such a time may be as is convenient to the patient 111, or according to a selected maximum time interval dictated by the treatment regimen and protocol, or as is required to replenish the power source 119 of the portable device 112, or in accordance with other requirements of the system 100.
- the protocol or other intelligent message reviews and compares the information provided by the patient 111 to the requirements of the treatment regimen in order to evaluate the effectiveness of the treatment regimen toward achieving treatments objectives and as to compliance of the patient 11 1 with the treatment regimen.
- the protocol may then leave the treatment regimen unchanged or modify it as needed to increase effectiveness and/or compliance; in either case, the server device 160 sends a message to the patient device 110 as to the regimen to be followed from the that time forward.
- the server device 160 also sends that message to the pharmacist device 140 and the medical professional device 150.
- information regarding the entire course of the treatment regimen can be stored by each of those devices and displayed on demand.
- only the server records the entire course, or only selected devices, or some combination thereof.
- the portable device 112 when a treatment regimen requires a patient 1 11 to take one or more medications, the portable device 112 is coupled to the medication dispenser 109 containing medication specified by the treatment regimen. In an alternative embodiment, the portable device 112 also controls the medication dispenser 109 so as to release only the correct dosage of the correct medication at the correct time responsive to the treatment regimen.
- the dispenser 109 automatically provides feedback to the portable device 1 12 when the correct medication is removed, canceling the reminder message and storing the feedback for subsequent downloading to the patient device 110 on the next occasion that the portable device 112 is coupled to the patient device 110.
- the patient device 110 can be any device for electronic communication including, but not limited to, and application specific device, a hard-wired telephone, a cellular telephone, a pager, the personal desktop computer, a personal notebook computer, a hand-held computing device, and Internet appliance, an Internet-enabled television such as WebTV, personal digital assistants such as the Palm III, or any variant thereof.
- the portable device 112 can be any portable device for electronic communication which is capable of being coupled to the patient device 110 including, without limitation, an application specific device, a cellular telephone, a pager, a personal notebook computer, a hand-held computing device, an Internet appliance, a personal digital assistant such as the Palm III, a watch, or any variant thereof.
- the feedback input element 118 can be any means of providing input to an electric communication device including, but not limited to, a button, a telephone key, a computer keyboard key, a voice-response activator, or any variant or combination thereof.
- FIGURE 3 shows a process flow diagram of a method for operating a system for leveraging expert interaction with a community of individuals to encourage compliance with a treatment regimen and for collecting and imparting information relevant to treatment regimen.
- a method 200 is performed by the system 100, as follows. At a flow point 201, the system 100 is ready to proceed. At a step 202, the service provider enters information concerning a treatment regimen and protocol to be followed by the patient 111. At a step 203, the treatment regimen and protocol information is sent to the server device 160 using the communications network 130. At a step 204, the server device 160 records the treatment regimen and protocol information received from the service provider in the database 161.
- the server device 160 sends treatment regimen and protocol information to the patient device 110, the pharmacist device 140 and the medical professional device 150 using the communication network 130. In alternative embodiments, the server device 160 may send the treatment regimen and protocol information only to the patient device 110.
- the portable device 112 is coupled to the patient device 110 and the treatment regimen and protocol information is copied into the memory 114 of the portable device 112.
- the portable device 112 is uncoupled from the patient device 110 and is taken with the patient 111 to a location relatively remote patient device 110.
- the patient device 110 uses the presentation element 117 to provide a reminder message to the patient 111 that an act is required to be performed by the patient 111 and instructs the patient 111 regarding the act to be performed.
- the patient 111 performs the indicated act as directed.
- the patient 111 operates the feedback input element 118 on the portable device 112, canceling the reminder message.
- the portable device 112 uses the presentation element 117 to query the patient 111 to provide information responsive to the protocol for evaluating the effectiveness of the treatment regimen.
- the patient 111 operates of the feedback input element 117 to provide information responsive to the queries, and that information is recorded in the memory 114.
- the portable device 112 is re-coupled to patient device 110.
- the information stored in the memory 114 is sent to the patient device 110, which in turn sends that information to the server device 160 using the communication network 130.
- the information received by the server device 160 is recorded in the database 161.
- the server device 160 sends the information received from the patient device 110 to the pharmacist device 140 and to the medical professional device 150 using the communication network 130. In an alternate embodiment, the server device 160 does not send the information received from the patient device 110 to the pharmacist device 140 or to the medical professional device 150, whether using the communication network 130 or otherwise.
- the information received by the server device 160 from the patient device 110 is evaluated by the protocol.
- the protocol updates the treatment regimen and either leaves it unchanged or modifies it in accordance with protocol logic.
- the server device 160 sends the updated treatment regimen information to the patient device 110, to the pharmacist device 140 and to the medical professional device 150, using the communications network 130. In an alternative embodiment, the server device 160 does not send the updated treatment regimen information to the pharmacist device 140 or the medical professional device 150.
- step 220 the pharmacist 141 and/or the medical professional 151 review and compare the original treatment regimen, the compliance and other information input by the patient 111, and the updated treatment regimen, and either leave the updated treatment regimen and protocol information unchanged or modify it as necessary. In an alternative embodiment, step 220 does not take place.
- the treatment regimen and protocol information as unchanged or as modified by the pharmacist 141 and/or the medical professional 151 is sent to the server device 160 using the communication network 130. In an alternative embodiment, step 221 does not take place.
- the server device 160 records the treatment regimen and protocol information as unchanged or as modified by the pharmacist 141 and/or the medical professional 151 in the database 161. In an alternative embodiment, step 222 does not take place.
- the server device 160 sends the treatment regimen and protocol information as unchanged or as modified by the pharmacist 141 and/or the medical professional 151 to the patient device 110 using the communication network 130. In an alternative embodiment, step 223 does not take place.
- the patient device 110 sends the updated treatment regimen information to portable device 112 and it is recorded in the memory 114.
- the patient device 110 replenishes the charge of the power source 119.
- the patient 111 uncouples the portable device 112 from the patient device 110.
- the pharmacist 141 provides a refill or new medicine to the patient 111 responsive to the treatment regimen and protocol information. In an alternative embodiment, step 227 does not take place.
- FIGURE 4 shows a first embodiment of the controlled medication dispenser 109 used by the system 100.
- the medication dispenser 109 includes one or more medication compartments 313. Each medication compartment 313 is labeled with a human-readable identifying letter or symbol 314 on or immediately adjacent to the medication compartment 313.
- the medication compartment 313 are filled with medication by the pharmacist 141, the medical professional 150, the patient 111 or other supplier.
- the pharmacist 141 enters medication regimen information regarding the patient 111 into the pharmacist device 140 which sends it to the server device 160 where it is recorded in the database 161.
- the server device 160 then sends the medication regimen information to the patient device 110 and optionally to the medical professional device 150.
- the patient device 110 sends a reminder message to the patient 11 1 indicating that a medication is to be taken, indicating the letter or identifying symbol 314 of the medication compartment 313 containing the medication to be taken, and indicating the dosage of medication to be taken.
- the patient 111 then manually opens the indicated medication compartment 313 and takes the indicated dosage of the medication contained there.
- the patient 111 enters a message that the medication has been taken into the patient device 110 using a signifying device 324, shown in FIGURE 8, which cancels the reminder message and sends the message that the medication has been taken to the server device 160 where it is recorded in the database 160.
- the server device 160 then sends the message that the medication has been taken to the pharmacist device 140 and optionally to the medical professional device 150.
- the medication dispenser 109 is not directly coupled to the patient device 110 and is controlled entirely by the patient 111.
- the patient device 110 can be any device for electronic dommunication including, but not limited to, an application specific device, a hard-wired telephone, a cellular telephone, a pager, a personal desktop computer, a personal notebook computer, a hand-held computing device, an internet appliance, an internet-enabled television, such as Web TV, or personal digital assistant, such as the Palm III.
- the signifying device 324 can be any means of providing input to an electronic communication device including, but not limited to, a button, a telephone key, a computer keyboard key, or a voice-response activator.
- FIGURE 5 shows a second embodiment of the controlled medication dispenser
- the medication dispenser 109 used by the system 100.
- the medication dispenser 109 as in the first embodiment and also including a unique identifying device 316, either as part of the medication dispenser 109 itself or as part of a module attached to the medication dispenser 109.
- the unique identifying device 316 provides positive identification of the medication dispenser 109 to the patient device 110 to reduce the risk of error when dispensing medication to the patient 111.
- the unique identifying device 316 can be any device capable of providing positive identification including, but not limited to, a smart card.
- FIGURE 6 shows a third embodiment of the controlled medication dispenser 109 used by the system 100.
- the medication dispenser 109 is similar to the second embodiment but without the identifying letter or symbol 314 but including a LED or equivalent 317 located on or immediately adjacent to each medication compartment 313.
- the medication compartment 313 containing the medication to be taken is identified responsive to the patient device 110 or the portable device 112, see FIGURE 8 below, by illumination of the LED 317.
- FIGURE 7 shows a fourth embodiment of the controlled medication dispenser
- the medication dispenser 109 used by the system 100.
- the medication dispenser 109 as in the third embodiment but with the LED 317 replaced by a single digit display 318 that is located on or immediately adjacent to each medication compartment 313.
- the medication compartment 313 containing the medication to be taken is identified responsive to the patient device 110 by illumination of the single digit display 318, which also indicates the number of medications to be taken from that medication compartment 313.
- FIGURE 8 shows a fifth embodiment of the controlled medication dispenser 109 used by the system 100.
- the medication dispenser 109 as in the third embodiment is made portable by connection to the portable device 112.
- the portable device 112 is programmed with the medication regimen information by the patient device 110, the pharmacist device 140, or the medical professional device 150, to which the portable device is connected as necessary. Times when a medication is to be taken by the patient 111 according to the medication regimen are identified by the clock 116 and the processor chip 115.
- the processor chip 115 then causes the LED 317, that is located on or immediately adjacent to the medication compartment 313 containing the medication to be taken, to be illuminated.
- the processor chip 115 also causes an audible warning device to produce a sound, which can be heard by the patient 111.
- the patient 111 After taking the indicated medication dosage the patient 111 operates the signifying device 324, cancelling illumination of the LED 317 and production of sound by the audible warning device, and further causing the portable device 112 to record the time at which the patient 111 operated the signifying device 324 for downloading to the patient device 112, the pharmacist device 140 or the medical professional device 150 the next time the patient device 112 is connected to such device.
- FIGURE 9 shows a sixth embodiment of the controlled medication dispenser 109 used by the system 100.
- the medication dispenser 109 as in the fifth embodiment, and also including a single digit display 325 located on the portable device 112 attached to the medication dispenser 109.
- the processor chip 115 causes the single digit display 325 to illuminate and display a number indicating the number of medications to be taken from the compartment 313 identified by the LED 317.
- FIGURE 10 shows a seventh embodiment of the controlled medication dispenser 109 used by the system 100.
- the medication dispenser 109 as in the second embodiment, and also including a portable device 112 as in the fifth embodiment but with the single digit display 325 replaced by a two digit display 326 located on the portable device 112 attached to the medication dispenser 109.
- the processor chip 115 causes the two digit display 326 to illuminate and display both the identifying letter or symbol of the medication compartment 313 containing the medication to be taken, as well as to display a number indicating the number of medications to be taken from the compartment 313.
- two single digit displays are included in the portable device 112 rather than a single two-digit display.
- the unique identifying device 316 is a smart card or equivalent into which the pharmacist 141 can enter additional information such as the name of the patient 111, names of medications, location of medications in the medication compartments 313, dosage of medications, timing of dosages, etc., and such additional information can be read from the smart card or equivalent by the patient device 110, by the medical professional 151 with an attachment 152 to the medical professional device 150, or by the portable device 112.
- the portable device 112 includes an enhanced processor chip which can interpret medication regimen information recorded in the unique identifying device 316 such as timing and amount of dosage, and which can operate independently of the patient device 110 to provide through the portable device 112 a reminder message indicating that a dosage is to be taken.
- FIGURE 11 shows a process flow diagram of a method for communication with feedback to dispense medicine.
- a method 400 is performed by the system 100, including the patient device 110, the pharmacist device 140, the medical professional device 150, and the server device 160.
- the system 100 is ready to proceed.
- the medication dispenser 109 is filled with one or more medications by the pharmacist 141 or the patient 111.
- the pharmacist 141 enters into the pharmacist device 140 information concerning the medication regimen to be followed by the patient 111.
- such medication regimen information includes type of medication, timing of dosage, quantity of dosage, and identification of compartments 313 in the medication dispenser 109.
- the pharmacist device 140 sends the medication regimen information to the server device 160 using the communications network 130.
- the server device 160 records the medication regimen information received from the pharmacist device 140 in the database 161.
- the server device 160 sends the medication regimen information to the patient device 110 and to the medical professional device 150 using the communication network 130.
- the server device 160 sends the medication regimen information only to the patient device 110.
- the patient device 110 responsive to the medication regiment information, provides a warning message to the patient 111 when a medication is to be taken and also instructs the patient 111 regarding which compartment 313 in the medication dispenser 109 contains the medication and what dosage of that medication is to be taken.
- the patient 111 removes the dosage of medication to be taken from the indicated compartment 313 and takes the medication as directed.
- the patient communication device 110 controls the medication dispenser 112 so as to allow only the correct compartment 313 to open and so as to dispense only the correct dosage of medication.
- the patient 11 1 operates the signaling device 124 on the patient device 110 canceling the warning message to the patient and sending to the server device 160 a message that the medication has been taken by using the communication network 130.
- the server device 160 records in database 161 the message received from the patient device 110 that the medication has been taken.
- the server device 160 sends the message received from the patient device 110 that the medication has been taken to the pharmacist device 140 using communication network 130.
- the server device 160 also sends the message received from the patient device 110 that the medication has been taken to the medical professional device 150 using the communication network 130.
- the server device 160 does not send the message received from the patient device 110 that the medication has been taken to the medical professional device 150, either using the communication network 130 or otherwise.
- the medical professional 151 reviews the medication regimen information received from the pharmacist device 140 and compares it to the message received from the patient device 110 that the medication has been taken.
- the medical professional 151 does not review the medication regimen information received from the pharmacist device 140 and does not compare it to the message received from the patient device 110, either using the communication network 130 or otherwise.
- the medical professional 151 enters feedback regarding the compliance of the patient 100 with the medication regimen into the medical professional device 150. In an alternative embodiment the medical professional 151 does not provide feedback.
- the medical professional device 150 sends the feedback to the server device 160 using the communication network 130. In an alternative embodiment the medical professional device does not send feedback to the server device 160.
- the server device 160 records the feedback received from the medical professional device 150 in the database 161. In an alternative embodiment the server device 160 does not record feedback from the medical professional device 150.
- the server device 160 sends the feedback received from the medical professional device 150 to the patient device 110 and to the pharmacist device 140 using the communication network 130. In an alternative embodiment the server device 160 does not send feedback to the patient device 110 or the pharmacist device 140.
- the pharmacist 141 enters amended medication regimen information into the pharmacist device 140 responsive to the feedback received from the medical professional device 150. In an alternative embodiment the pharmacist 141 does not amend the medication regimen responsive to feedback from the medical professional device 150.
- the pharmacist device 140 sends the amended medication regimen information to the server device 160 using the communication network 130. In an alternative embodiment the pharmacist device 140 does not send amended medication regimen information to the server device 160.
- the server device 160 records the amended medication regimen information in the database 161. In an alternative embodiment the server device 160 does not record amended medication regimen information in the database 161.
- the server device 160 sends the amended medication regimen information to the patient device 110 and to the medical professional device 150 using the communication network 130. In an alternative embodiment the server device 160 does not send amended medication regimen information to the patient device 110 and to the medical professional device 150.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU20342/00A AU775435B2 (en) | 1998-12-01 | 1999-12-01 | System and method for executing a treatment regimen |
EP99964017A EP1146813A4 (en) | 1998-12-01 | 1999-12-01 | System and method for executing a treatment regimen |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20388098A | 1998-12-01 | 1998-12-01 | |
US09/203,880 | 1998-12-01 | ||
US09/216,012 US6161095A (en) | 1998-12-16 | 1998-12-16 | Treatment regimen compliance and efficacy with feedback |
US09/216,012 | 1998-12-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000032097A1 true WO2000032097A1 (en) | 2000-06-08 |
Family
ID=26898998
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/028296 WO2000032097A1 (en) | 1998-12-01 | 1999-12-01 | System and method for executing a treatment regimen |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1146813A4 (en) |
AU (1) | AU775435B2 (en) |
WO (1) | WO2000032097A1 (en) |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1172121A1 (en) * | 2000-07-13 | 2002-01-16 | PARI GmbH Spezialisten für effektive Inhalation | Aerosol therapy network |
EP1363224A1 (en) | 2002-05-15 | 2003-11-19 | Microlife Intellectual Property GmbH | A system for monitoring medical data, a terminal device for measuring and storing medical data, a medicine container and a holder for medicine containers |
DE10253728A1 (en) * | 2002-11-19 | 2004-06-24 | Hafner, Dieter, Dipl.-Phys. Dr.rer.nat. | Procedure for monitoring the intake of medication |
US7111756B2 (en) | 2000-10-20 | 2006-09-26 | Gw Pharma Limited | Dose dispensing apparatus |
US7295890B2 (en) | 2002-09-26 | 2007-11-13 | Stratamed Labs, Inc. | Prescription drug compliance monitoring system |
US7844361B2 (en) | 2002-09-26 | 2010-11-30 | Stratamed Labs, Inc. | Prescription drug compliance monitoring system |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8712748B2 (en) | 2007-06-27 | 2014-04-29 | Roche Diagnostics Operations, Inc. | Medical diagnosis, therapy, and prognosis system for invoked events and methods thereof |
US8818782B2 (en) | 2007-06-27 | 2014-08-26 | Roche Diagnostics Operations, Inc. | System for developing patient specific therapies based on dynamic modeling of patient physiology and method thereof |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US11160730B2 (en) | 2018-06-11 | 2021-11-02 | Rightis Technology, LLC | Smart medication dispensing system and method |
US12014328B2 (en) | 2005-07-13 | 2024-06-18 | Vccb Holdings, Inc. | Medicine bottle cap with electronic embedded curved display |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5390238A (en) * | 1992-06-15 | 1995-02-14 | Motorola, Inc. | Health support system |
US5408443A (en) | 1992-08-19 | 1995-04-18 | Polypharm Corp. | Programmable medication dispensing system |
US5642731A (en) | 1990-01-17 | 1997-07-01 | Informedix, Inc. | Method of and apparatus for monitoring the management of disease |
US5646912A (en) * | 1996-01-25 | 1997-07-08 | Cousin; Damon S. | Medication compliance, co-ordination and dispensing system |
US5752235A (en) * | 1990-01-17 | 1998-05-12 | Informedix, Inc. | Electronic medication monitoring and dispensing method |
US5827180A (en) * | 1994-11-07 | 1998-10-27 | Lifemasters Supported Selfcare | Method and apparatus for a personal health network |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5950632A (en) * | 1997-03-03 | 1999-09-14 | Motorola, Inc. | Medical communication apparatus, system, and method |
-
1999
- 1999-12-01 WO PCT/US1999/028296 patent/WO2000032097A1/en active IP Right Grant
- 1999-12-01 EP EP99964017A patent/EP1146813A4/en not_active Withdrawn
- 1999-12-01 AU AU20342/00A patent/AU775435B2/en not_active Ceased
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5642731A (en) | 1990-01-17 | 1997-07-01 | Informedix, Inc. | Method of and apparatus for monitoring the management of disease |
US5752235A (en) * | 1990-01-17 | 1998-05-12 | Informedix, Inc. | Electronic medication monitoring and dispensing method |
US5390238A (en) * | 1992-06-15 | 1995-02-14 | Motorola, Inc. | Health support system |
US5408443A (en) | 1992-08-19 | 1995-04-18 | Polypharm Corp. | Programmable medication dispensing system |
US5827180A (en) * | 1994-11-07 | 1998-10-27 | Lifemasters Supported Selfcare | Method and apparatus for a personal health network |
US5646912A (en) * | 1996-01-25 | 1997-07-08 | Cousin; Damon S. | Medication compliance, co-ordination and dispensing system |
Non-Patent Citations (1)
Title |
---|
See also references of EP1146813A4 * |
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1172121A1 (en) * | 2000-07-13 | 2002-01-16 | PARI GmbH Spezialisten für effektive Inhalation | Aerosol therapy network |
US7111756B2 (en) | 2000-10-20 | 2006-09-26 | Gw Pharma Limited | Dose dispensing apparatus |
US8845550B2 (en) | 2001-06-12 | 2014-09-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9802007B2 (en) | 2001-06-12 | 2017-10-31 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US9694144B2 (en) | 2001-06-12 | 2017-07-04 | Sanofi-Aventis Deutschland Gmbh | Sampling module device and method |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9560993B2 (en) | 2001-11-21 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US8905945B2 (en) | 2002-04-19 | 2014-12-09 | Dominique M. Freeman | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US8690796B2 (en) | 2002-04-19 | 2014-04-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9724021B2 (en) | 2002-04-19 | 2017-08-08 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9498160B2 (en) | 2002-04-19 | 2016-11-22 | Sanofi-Aventis Deutschland Gmbh | Method for penetrating tissue |
US9839386B2 (en) | 2002-04-19 | 2017-12-12 | Sanofi-Aventis Deustschland Gmbh | Body fluid sampling device with capacitive sensor |
US9072842B2 (en) | 2002-04-19 | 2015-07-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089678B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9089294B2 (en) | 2002-04-19 | 2015-07-28 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US9186468B2 (en) | 2002-04-19 | 2015-11-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
EP1363224A1 (en) | 2002-05-15 | 2003-11-19 | Microlife Intellectual Property GmbH | A system for monitoring medical data, a terminal device for measuring and storing medical data, a medicine container and a holder for medicine containers |
US7295890B2 (en) | 2002-09-26 | 2007-11-13 | Stratamed Labs, Inc. | Prescription drug compliance monitoring system |
US7844361B2 (en) | 2002-09-26 | 2010-11-30 | Stratamed Labs, Inc. | Prescription drug compliance monitoring system |
DE10253728A1 (en) * | 2002-11-19 | 2004-06-24 | Hafner, Dieter, Dipl.-Phys. Dr.rer.nat. | Procedure for monitoring the intake of medication |
US9034639B2 (en) | 2002-12-30 | 2015-05-19 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
US10034628B2 (en) | 2003-06-11 | 2018-07-31 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US9144401B2 (en) | 2003-06-11 | 2015-09-29 | Sanofi-Aventis Deutschland Gmbh | Low pain penetrating member |
US8945910B2 (en) | 2003-09-29 | 2015-02-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
US9561000B2 (en) | 2003-12-31 | 2017-02-07 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for improving fluidic flow and sample capture |
US9261476B2 (en) | 2004-05-20 | 2016-02-16 | Sanofi Sa | Printable hydrogel for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US12014328B2 (en) | 2005-07-13 | 2024-06-18 | Vccb Holdings, Inc. | Medicine bottle cap with electronic embedded curved display |
US8818782B2 (en) | 2007-06-27 | 2014-08-26 | Roche Diagnostics Operations, Inc. | System for developing patient specific therapies based on dynamic modeling of patient physiology and method thereof |
US8712748B2 (en) | 2007-06-27 | 2014-04-29 | Roche Diagnostics Operations, Inc. | Medical diagnosis, therapy, and prognosis system for invoked events and methods thereof |
US9386944B2 (en) | 2008-04-11 | 2016-07-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte detecting device |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US9795747B2 (en) | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
US11160730B2 (en) | 2018-06-11 | 2021-11-02 | Rightis Technology, LLC | Smart medication dispensing system and method |
Also Published As
Publication number | Publication date |
---|---|
AU775435B2 (en) | 2004-07-29 |
EP1146813A4 (en) | 2004-08-11 |
EP1146813A1 (en) | 2001-10-24 |
AU2034200A (en) | 2000-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU775435B2 (en) | System and method for executing a treatment regimen | |
US8015033B2 (en) | Treatment regimen compliance and efficacy with feedback | |
US6161095A (en) | Treatment regimen compliance and efficacy with feedback | |
US20080201168A1 (en) | Treatment regimen compliance and efficacy with feedback | |
US5642731A (en) | Method of and apparatus for monitoring the management of disease | |
US8483872B2 (en) | Smart medicine container | |
US7844361B2 (en) | Prescription drug compliance monitoring system | |
US6421650B1 (en) | Medication monitoring system and apparatus | |
US9492355B2 (en) | Smart medicine container | |
US20160247345A1 (en) | System and apparatus for displaying drug interactions on drug storage containers | |
US20110282693A1 (en) | Clinical management system and method | |
US7877268B2 (en) | Intelligent pill box | |
US20060124655A1 (en) | Smart Medicine Container | |
US20100096399A1 (en) | Smart Medicine Container | |
EP1034734A1 (en) | Method for improving patient compliance with a medical program | |
US10223504B2 (en) | Method, system and apparatus for medication therapy management programs | |
US20090259336A1 (en) | Smart Medicine Container Assembly | |
US20020064095A1 (en) | Method and apparatus for clinical trials | |
JPH01259866A (en) | Drug administration clock | |
WO2002025568A2 (en) | Pill identification and prescription management device, system and method | |
US20040179430A1 (en) | Pill dispensing reminder capable of communicating with a remotely situated computer | |
WO2001074229A2 (en) | Improving patient compliance with a medical program | |
US20040153339A1 (en) | Method and system for handling medical information | |
JP4558142B2 (en) | Electronic drug history management system | |
WO2003042789A2 (en) | Method and system for handling medical information |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REEP | Request for entry into the european phase |
Ref document number: 1999964017 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999964017 Country of ref document: EP Ref document number: 20342/00 Country of ref document: AU |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1999964017 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 20342/00 Country of ref document: AU |